GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lipidor AB (FRA:L7R) » Definitions » EBITDA Margin %

Lipidor AB (FRA:L7R) EBITDA Margin % : 0.00% (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Lipidor AB EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Lipidor AB's EBITDA for the three months ended in Dec. 2024 was €0.00 Mil. Lipidor AB's Revenue for the three months ended in Dec. 2024 was €0.00 Mil. Therefore, Lipidor AB's EBITDA margin for the quarter that ended in Dec. 2024 was 0.00%.


Lipidor AB EBITDA Margin % Historical Data

The historical data trend for Lipidor AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lipidor AB EBITDA Margin % Chart

Lipidor AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial -2,613.11 -138.41 -93,475.00 -13,557.14 -111,100.00

Lipidor AB Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6,966.67 -15,266.67 2,150.00 - -

Competitive Comparison of Lipidor AB's EBITDA Margin %

For the Drug Manufacturers - General subindustry, Lipidor AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Lipidor AB's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Lipidor AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Lipidor AB's EBITDA Margin % falls into.


;
;

Lipidor AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Lipidor AB's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-1.111/0.001
=-111,100.00 %

Lipidor AB's EBITDA Margin % for the quarter that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2024 )/Revenue (Q: Dec. 2024 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lipidor AB  (FRA:L7R) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Lipidor AB EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Lipidor AB's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Lipidor AB Business Description

Traded in Other Exchanges
Address
c/o Ekonomistubben AB, Box 55931, Stockholm, SWE, 102 16
Lipidor AB is a pharmaceutical development company with a pipeline of drug development projects in the preclinical and clinical phases. The company develops drugs for the treatment of skin diseases such as psoriasis, bacterial skin infections, and atopic dermatitis.

Lipidor AB Headlines

No Headlines